Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology#Sanofi #acquire #Blueprint #Medicines #expanding #portfolio #rare #immunological #disease #adding #earlystage #pipeline #immunology